U.S. Spatial Genomics & Transcriptomics Market Size & Outlook
U.S. spatial genomics & transcriptomics market, 2018-2030 (US$M)
Related Markets
U.S. spatial genomics & transcriptomics market highlights
- The U.S. spatial genomics & transcriptomics market generated a revenue of USD 124.5 million in 2023 and is expected to reach USD 243.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Spatial genomics & transcriptomics market data book summary
| Market revenue in 2023 | USD 124.5 million |
| Market revenue in 2030 | USD 243.2 million |
| Growth rate | 10% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Software |
| Key market players worldwide | Natera Inc, 10x Genomics Inc Ordinary Shares - Class A, Dovetail Genomics, Illumina Inc, NanoString Technologies, Seven Bridges, Horizon Discovery, Bio-Techne Corp, S2 Genomics |
Other key industry trends
- In terms of revenue, U.S. accounted for 40.2% of the global spatial genomics & transcriptomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. spatial genomics & transcriptomics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 23.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Spatial Genomics & Transcriptomics Market Scope
Spatial Genomics & Transcriptomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. spatial genomics & transcriptomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to spatial genomics & transcriptomics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 52.77% in 2023. Horizon Databook has segmented the U.S. spatial genomics & transcriptomics market based on instruments, consumables, software covering the revenue growth of each sub-segment from 2018 to 2030.
According to estimates by American Society of Cancer, 1,688,780 new cancer cases were reported in the U.S. in 2017. Moreover, ongoing strategic investments in cancer research have rendered the U.S. a global leader in the field. Cancer Prevention and Control Research Network is a flagship program initiated by CDC for prevention of cancer.
Through colorectal cancer prevention and control initiatives, CDC is conducting and promoting screening for colorectal cancer. Alzheimer’s disease is the sixth leading cause of death in the U.S. Therefore, increase in prevalence of chronic disorders in the U.S. is expected to drive demand for advanced diagnostic & treatment
Methods based on spatial genomics and transcriptomics. In addition, due to continuous development in technologies, a single tissue sample can now be used to detect multiple abnormalities. This has led to an increase in adoption of genomicsbased diagnosis techniques.
Reasons to subscribe to U.S. spatial genomics & transcriptomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. spatial genomics & transcriptomics market databook
-
Our clientele includes a mix of spatial genomics & transcriptomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. spatial genomics & transcriptomics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. spatial genomics & transcriptomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. spatial genomics & transcriptomics market size, by product, 2018-2030 (US$M)
U.S. Spatial Genomics & Transcriptomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
